Stop Fighting Hunger. Start Losing Weight.

Weight loss injections, such as Wegovy and Mounjaro, are injectable medications designed to help people lose weight by reducing appetite and regulating blood sugar levels. These treatments are ideal for individuals who have struggled to lose weight through diet and exercise alone.

Injectable weight loss treatments work by mimicking hormones in your body that regulate hunger, leading to reduced food intake and weight loss over time. Medications like Wegovy and Mounjaro are clinically proven to support weight loss when combined with a healthy diet and regular exercise​.

At My London Pharmacy, we provide various weight loss injections such as Mounjaro, Wegovy, and Saxenda, which are designed to support weight loss when combined with a healthy diet and regular exercise. These treatments can be a helpful addition to a comprehensive weight loss plan, but they should be used only when necessary to achieve and maintain a healthy weight.

In the UK, weight loss injection pens represent a relatively new option for weight management. Saxenda was the first widely recognized option, introduced in 2020, and since then, other treatments have become available. Below is a summary of the main weight loss injections currently offered in the UK.

The best way to lose weight using injections is to follow a treatment plan that includes regular injections, a balanced diet, and consistent physical activity. At My London Pharmacy, our prescribing pharmacists guide you through the process to ensure you achieve the best possible results.

Yes, weight loss injections can help you lose weight faster than traditional methods alone. However, it’s important to follow your healthcare provider's recommendations for safe and effective weight loss. Injectable treatments are most effective when used alongside lifestyle changes​.

Yes, weight loss injections are available in the UK through My London Pharmacy. We offer a range of options tailored to your needs, delivered directly to your door after an online consultation with our experienced prescribing pharmacists.

Choosing the right weight loss injection depends on your health profile, weight loss goals, and lifestyle. Our team at My London Pharmacy will assess your needs during your consultation to recommend the best injectable treatment for your weight loss journey.

Mounjaro weight loss injection pen, shows an average weight loss of around 20% in clinical trials. This surpasses the results of Saxenda 8%, and Wegovy 15%.

Mounjaro contains the active ingredient tirzepatide and is administered once weekly.

Like other weight loss injections, Mounjaro starts with a low dose, which is gradually increased to minimize side effects. The starting dose is 2.5 mg, with the highest maintenance dose being 15 mg (Mounjaro Summary of Product Characteristics, emc).

What is Wegovy?
Wegovy is a prescription weekly injectable weight-loss medication containing semaglutide, approved in the UK and Europe for managing overweight and obesity alongside diet and increased physical activity.

How does it work?
Semaglutide mimics the GLP-1 hormone, which helps regulate appetite and promote feelings of fullness, reducing calorie intake and supporting weight loss.

Typical weight loss results:

• In clinical studies, adults with obesity or overweight (with at least one weight-related comorbidity) lost on average about 15% of their starting body weight over ~68 weeks compared with around 2.5-3% in placebo groups.

• Around 76% of patients achieve at least 5% weight loss, a clinically meaningful threshold.

BMI Eligibility (UK/EU guidance):
Approved criteria (EU/EMA and UK prescribing practice) for semaglutide (Wegovy) indicate eligibility if you are an adult with:

• BMI ≥ 30 kg/m² (obesity), or

• BMI ≥ 27 kg/m² with at least one weight-related health problem (e.g., type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea)

Saxenda is the original weight loss pen and has been available in the UK since 2020. On average, patients using Saxenda can expect to lose around 8% of their body weight during the course of treatment .

The active ingredient in Saxenda is liraglutide, which is related to semaglutide and is also a GLP-1 agonist. Saxenda works similarly to Wegovy by reducing appetite, but it is administered daily rather than weekly. It is prescribed to patients with a BMI of over 30, or over 27 with additional risk factors.